Anticarcinogens, such as MTX and CTX, can induce immunogenic cell death (31, 32), which can increase the function of cytotoxic T cells and activate the type I interferon signaling pathway; thus, this phenomenon may explain the treatment failure of these two drugs in MOG-AD. The gene discussed is MOG; the disease is Alzheimer disease.